Missed seeing the August VBPS event on the Design of PCSK9 Inhibitor Peptides? Have no fear, the videos are here!
On August 2nd, Chengwei Wu and Li Li, both from Merck Research Laboratories, each gave a talk on how helped to develop an orally bioavailable, tricyclic peptide PCSK9 inhibitor. Each speaker presented for 30 minutes followed by a moderated panel discussion and Q&A session.
Recordings of the seminar are available at www.boulderpeptide.org/virtual-bps/. *Please note - you must be logged in to the Boulder Peptide website to access the link*
These educational e-seminars are provided free of charge by the Boulder Peptide Foundation. If your company is interested in supporting this or other educational initiatives, please email sponsorship@boulderpeptide.org.